CN106473946A - A kind of anti-acne elite dew and preparation method thereof - Google Patents
A kind of anti-acne elite dew and preparation method thereof Download PDFInfo
- Publication number
- CN106473946A CN106473946A CN201611108742.1A CN201611108742A CN106473946A CN 106473946 A CN106473946 A CN 106473946A CN 201611108742 A CN201611108742 A CN 201611108742A CN 106473946 A CN106473946 A CN 106473946A
- Authority
- CN
- China
- Prior art keywords
- acne
- paeonol
- laurocapram
- mentholum
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of anti-acne elite dew and preparation method thereof, by weight percentage, including following component：Pharmaceutical grade 95% ethanol 85.0 95.0%；13 butanediols 0.3 0.8%；Vitamin E 0.3 0.8%；Salicylic acid powder 0.5 3%；Mentholum 0.5 3%；Paeonol 2 8%；Laurocapram 0.1 0.4%.The anti-acne elite dew of the present invention, energy removing acne, reduces growing again of comedo, the acne print staying after desalination comedo healing, and desalination pityrosporion ovale folliculitises, golden yellow staphylococcus and scalds the impression that property dermatitis stays.
Description
Technical field
The present invention relates to cosmetic field, more particularly, to a kind of anti-acne elite dew and preparation method thereof.
Background technology
Comedo, also known as acne, is a kind of pilosebaceous chronic inflammatory skin, is mainly apt to occur in teenager, main
Showing as the pleomorphism skin lesion such as facial acne, pimple, pustule, tuberosity is feature.The pathogenic factor of comedo is multifactor
It has been found that linoleic acid in sebum reduce relevant with the generation of variola；Because comedo takes place mostly in adolescence, this is sensitive
Age bracket, it is impaired that sense of personal worth easily in patient, depressed at heart, society's problem at heart such as feel oneself inferior, the social activity to patient and just
Industry produces a certain degree of impact, therefore needs a kind of determined curative effect, product for resolving poxes safe and free of toxic and side effects badly.
Product for resolving poxes in the market is various, but generally existing anti-acne effect is inconspicuous, and print of dispelling effect difference is it is impossible to reach
The problem taken stopgap measures and effect a permanent cure.
Therefore, prior art has yet to be improved and developed.
Content of the invention
In view of above-mentioned the deficiencies in the prior art, it is an object of the invention to provide a kind of anti-acne elite dew and its preparation side
, it is intended to the existing product for resolving poxes anti-acne effect of solution is inconspicuous, print of dispelling effect difference is it is impossible to reach the problem taken stopgap measures and effect a permanent cure for method.
In order to achieve the above object, this invention takes technical scheme below：
A kind of anti-acne elite dew, wherein, by weight percentage, including following component：
Pharmaceutical grade 95% ethanol 85.0-95.0%；
13 butanediol 0.3-0.8%；
Vitamin E 0.3-0.8%；
Salicylic acid powder 0.5-3%；
Mentholum 0.5-3%；
Paeonol 2-8%；
Laurocapram 0.1-0.4%.
Described anti-acne elite dew, wherein, by weight percentage, including following component：
Pharmaceutical grade 95% ethanol 88.0-92.0%；
13 butanediol 0.4-0.6%；
Vitamin E 0.4-0.6%；
Salicylic acid powder 0.8-2.0%；
Mentholum 0.8-2.0%；
Paeonol 4-8%；
Laurocapram 0.1-0.2%.
Described anti-acne elite dew, wherein, by weight percentage, is made up of following component：
Pharmaceutical grade 95% ethanol 88.9%；
13 butanediols 0.5%；
Vitamin E 0.5%；
Salicylic acid powder 1%；
Mentholum 1%；
Paeonol 8%；
Laurocapram 0. 1%.
Described anti-acne elite dew, wherein, by weight percentage, is made up of following component：
Pharmaceutical grade 95% ethanol 88.0%；
13 butanediols 0.4%；
Vitamin E 0.4%；
Salicylic acid powder 2.0%；
Mentholum 2.0%；
Paeonol 7%；
Laurocapram 0.2%.
Described anti-acne elite dew, wherein, by weight percentage, is made up of following component：
Pharmaceutical grade 95% ethanol 92.0%；
13 butanediols 0.6%；
Vitamin E 0.6%；
Salicylic acid powder 0.8%；
Mentholum 0.8%；
Paeonol 5%；
Laurocapram 0.2%.
Described anti-acne elite dew, wherein, by weight percentage, is made up of following component：
Pharmaceutical grade 95% ethanol 85%；
13 butanediols 0.8%；
Vitamin E 0.8%；
Salicylic acid powder 3%；
Mentholum 2%；
Paeonol 8%；
Laurocapram 0.4%.
The preparation method of a kind of as above arbitrary described anti-acne elite dew, wherein, comprises the following steps：
A, according to above-mentioned formula, pharmaceutical grade 95% ethanol, 13 butanediols and Vitamin E are mixed, obtain the first mixture；
B, by salicylic acid powder, Mentholum, paeonol and laurocapram mix, obtain the second mixture；
C, by the first mixture and second mixture mix and blend 15 ~ 25min, obtain anti-acne elite dew.
The preparation method of described anti-acne elite dew, wherein, in step C, mix and blend 20min.
Beneficial effect：The anti-acne elite dew of the present invention, energy removing acne, reduces growing again of comedo, desalination is blue or green
The acne print staying after the healing of spring pox, and the impression that desalination pityrosporion ovale folliculitises, golden yellow staphylococcus scald property dermatitis stay.
Specific embodiment
The present invention provides a kind of anti-acne elite dew and preparation method thereof, for making the purpose of the present invention, technical scheme and effect
Clearer, clear and definite, the present invention is described in more detail below.It should be appreciated that specific embodiment described herein is only
In order to explain the present invention, it is not intended to limit the present invention.
A kind of anti-acne elite dew of the present invention, wherein, by weight percentage, including following component：
Pharmaceutical grade 95% ethanol 85.0-95.0%；
13 butanediol 0.3-0.8%；
Vitamin E 0.3-0.8%；
Salicylic acid powder 0.5-3%；
Mentholum 0.5-3%；
Paeonol 2-8%；
Laurocapram 0.1-0.4%.
According to above-mentioned formula, prepared anti-acne elite is revealed, and energy removing acne reduces growing again of comedo, desalination
The acne print staying after comedo healing, and the impression that desalination pityrosporion ovale folliculitises, golden yellow staphylococcus scald property dermatitis stay.
Even more preferably, by weight percentage, including following component：
Pharmaceutical grade 95% ethanol 88.0-92.0%；
13 butanediol 0.4-0.6%；
Vitamin E 0.4-0.6%；
Salicylic acid powder 0.8-2.0%；
Mentholum 0.8-2.0%；
Paeonol 4-8%；
Laurocapram 0.1-0.2%.
According to above-mentioned optimization formula, effect that prepared anti-acne elite is revealed is more preferably.
The preparation method of a kind of as above arbitrary described anti-acne elite dew of the present invention, wherein, comprises the following steps：
A, according to above-mentioned formula, pharmaceutical grade 95% ethanol, 13 butanediols and Vitamin E are mixed, obtain the first mixture；
B, by salicylic acid powder, Mentholum, paeonol and laurocapram mix, obtain the second mixture；
C, by the first mixture and second mixture mix and blend 15 ~ 25min, obtain anti-acne elite dew.
Below by embodiment, the present invention is described in detail.
Embodiment 1
Anti-acne elite is revealed, and by weight percentage, is made up of following component：
Pharmaceutical grade 95% ethanol 88.9%；
13 butanediols 0.5%；
Vitamin E 0.5%；
Salicylic acid powder 1%；
Mentholum 1%；
Paeonol 8%；
Laurocapram 0. 1%.
The preparation method of above-mentioned anti-acne elite dew, comprises the following steps：
（1）, according to above-mentioned formula, pharmaceutical grade 95% ethanol, 13 butanediols and Vitamin E are mixed, obtain the first mixture；
（2）, by salicylic acid powder, Mentholum, paeonol and laurocapram mix, obtain the second mixture；
（3）, by the first mixture and the second mixture mix and blend 20min, obtain anti-acne elite dew.
Embodiment 2
Anti-acne elite is revealed, and by weight percentage, is made up of following component：
Pharmaceutical grade 95% ethanol 88.0%；
13 butanediols 0.4%；
Vitamin E 0.4%；
Salicylic acid powder 2.0%；
Mentholum 2.0%；
Paeonol 7%；
Laurocapram 0.2%.
The preparation method of above-mentioned anti-acne elite dew, comprises the following steps：
（1）, according to above-mentioned formula, pharmaceutical grade 95% ethanol, 13 butanediols and Vitamin E are mixed, obtain the first mixture；
（2）, by salicylic acid powder, Mentholum, paeonol and laurocapram mix, obtain the second mixture；
（3）, by the first mixture and the second mixture mix and blend 15min, obtain anti-acne elite dew.
Embodiment 3
Anti-acne elite is revealed, and by weight percentage, is made up of following component：
Pharmaceutical grade 95% ethanol 92.0%；
13 butanediols 0.6%；
Vitamin E 0.6%；
Salicylic acid powder 0.8%；
Mentholum 0.8%；
Paeonol 5%；
Laurocapram 0.2%.
The preparation method of above-mentioned anti-acne elite dew, comprises the following steps：
（1）, according to above-mentioned formula, pharmaceutical grade 95% ethanol, 13 butanediols and Vitamin E are mixed, obtain the first mixture；
（2）, by salicylic acid powder, Mentholum, paeonol and laurocapram mix, obtain the second mixture；
（3）, by the first mixture and the second mixture mix and blend 25min, obtain anti-acne elite dew.
Embodiment 4
Anti-acne elite is revealed, and by weight percentage, is made up of following component：
Pharmaceutical grade 95% ethanol 85%；
13 butanediols 0.8%；
Vitamin E 0.8%；
Salicylic acid powder 3%；
Mentholum 2%；
Paeonol 8%；
Laurocapram 0.4%.
The preparation method of above-mentioned anti-acne elite dew, comprises the following steps：
（1）, according to above-mentioned formula, pharmaceutical grade 95% ethanol, 13 butanediols and Vitamin E are mixed, obtain the first mixture；
（2）, by salicylic acid powder, Mentholum, paeonol and laurocapram mix, obtain the second mixture；
（3）, by the first mixture and the second mixture mix and blend 20min, obtain anti-acne elite dew.
In sum, the anti-acne elite dew of the present invention, energy removing acne, reduce growing again of comedo, and desalination is blue or green
The acne print staying after the healing of spring pox, and the impression that desalination pityrosporion ovale folliculitises, golden yellow staphylococcus scald property dermatitis stay.
It should be appreciated that the application of the present invention is not limited to above-mentioned citing, for those of ordinary skills, can
To be improved according to the above description or to convert, all these modifications and variations all should belong to the guarantor of claims of the present invention
Shield scope.
Claims (8)
1. a kind of anti-acne elite is revealed it is characterised in that by weight percentage, including following component：
Pharmaceutical grade 95% ethanol 85.0-95.0%；
13 butanediol 0.3-0.8%；
Vitamin E 0.3-0.8%；
Salicylic acid powder 0.5-3%；
Mentholum 0.5-3%；
Paeonol 2-8%；
Laurocapram 0.1-0.4%.
2. anti-acne elite according to claim 1 is revealed it is characterised in that by weight percentage, including following component：
Pharmaceutical grade 95% ethanol 88.0-92.0%；
13 butanediol 0.4-0.6%；
Vitamin E 0.4-0.6%；
Salicylic acid powder 0.8-2.0%；
Mentholum 0.8-2.0%；
Paeonol 4-8%；
Laurocapram 0.1-0.2%.
3. anti-acne elite according to claim 1 and 2 is revealed it is characterised in that by weight percentage, by following component group
Become：
Pharmaceutical grade 95% ethanol 88.9%；
13 butanediols 0.5%；
Vitamin E 0.5%；
Salicylic acid powder 1%；
Mentholum 1%；
Paeonol 8%；
Laurocapram 0. 1%.
4. anti-acne elite according to claim 1 and 2 is revealed it is characterised in that by weight percentage, by following component group
Become：
Pharmaceutical grade 95% ethanol 88.0%；
13 butanediols 0.4%；
Vitamin E 0.4%；
Salicylic acid powder 2.0%；
Mentholum 2.0%；
Paeonol 7%；
Laurocapram 0.2%.
5. anti-acne elite according to claim 1 and 2 is revealed it is characterised in that by weight percentage, by following component group
Become：
Pharmaceutical grade 95% ethanol 92.0%；
13 butanediols 0.6%；
Vitamin E 0.6%；
Salicylic acid powder 0.8%；
Mentholum 0.8%；
Paeonol 5%；
Laurocapram 0.2%.
6. anti-acne elite according to claim 1 is revealed it is characterised in that by weight percentage, is made up of following component：
Pharmaceutical grade 95% ethanol 85%；
13 butanediols 0.8%；
Vitamin E 0.8%；
Salicylic acid powder 3%；
Mentholum 2%；
Paeonol 8%；
Laurocapram 0.4%.
7. a kind of preparation method of described anti-acne elite dew as arbitrary in claim 1 ~ 6 is it is characterised in that include following walking
Suddenly：
A, according to above-mentioned formula, pharmaceutical grade 95% ethanol, 13 butanediols and Vitamin E are mixed, obtain the first mixture；
B, by salicylic acid powder, Mentholum, paeonol and laurocapram mix, obtain the second mixture；
C, by the first mixture and second mixture mix and blend 15 ~ 25min, obtain anti-acne elite dew.
8. the preparation method of anti-acne elite according to claim 7 dew is it is characterised in that in step C, mix and blend
20min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611108742.1A CN106473946A (en) | 2016-12-06 | 2016-12-06 | A kind of anti-acne elite dew and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611108742.1A CN106473946A (en) | 2016-12-06 | 2016-12-06 | A kind of anti-acne elite dew and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106473946A true CN106473946A (en) | 2017-03-08 |
Family
ID=58275628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611108742.1A Pending CN106473946A (en) | 2016-12-06 | 2016-12-06 | A kind of anti-acne elite dew and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106473946A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107349149A (en) * | 2017-07-25 | 2017-11-17 | 广州铭心化妆品有限公司 | A kind of anti-acne essence and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1090173A (en) * | 1993-10-28 | 1994-08-03 | 广东医学院医药科技开发中心 | A kind of prescription and preparation thereof that promotes that drug transdermal absorbs |
| CN101015509A (en) * | 2007-02-14 | 2007-08-15 | 郑州三创释药技术有限公司 | Cosmetic product for treating acne |
| CN102824289A (en) * | 2012-09-18 | 2012-12-19 | 铜陵洁雅生物科技股份有限公司 | Oil control and acne removal wet tissue |
-
2016
- 2016-12-06 CN CN201611108742.1A patent/CN106473946A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1090173A (en) * | 1993-10-28 | 1994-08-03 | 广东医学院医药科技开发中心 | A kind of prescription and preparation thereof that promotes that drug transdermal absorbs |
| CN101015509A (en) * | 2007-02-14 | 2007-08-15 | 郑州三创释药技术有限公司 | Cosmetic product for treating acne |
| CN102824289A (en) * | 2012-09-18 | 2012-12-19 | 铜陵洁雅生物科技股份有限公司 | Oil control and acne removal wet tissue |
Non-Patent Citations (2)
| Title |
|---|
| 侯刚健等: "牡丹皮酊的制备及临床治疗寻常型痤疮疗效观察", 《辽宁中医药大学学报》 * |
| 广州丹草生物科技有限公司: ""康芝奇祛痘精华露"", 《国产非特殊用途化妆品备案服务平台》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107349149A (en) * | 2017-07-25 | 2017-11-17 | 广州铭心化妆品有限公司 | A kind of anti-acne essence and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105616280B (en) | One kind is releived antiallergic maintenance ice pellets water | |
| EP1940432B1 (en) | Anti-inflammatory compositions and methods of use | |
| JP5284093B2 (en) | Anti-inflammatory compositions and methods of use | |
| KR20160047914A (en) | Anti-aging cosmetic composition comprising precursor of Nicotinamide adenine dinucleotide | |
| US20200197359A1 (en) | Cannabinoid and Terpene-Infused Topical Cream | |
| JP2015528499A (en) | Formulation containing idebenone, N-acetyl-S-farnesyl-L-cysteine and ergothioneine and use thereof | |
| CN112423771A (en) | Virus inactivating agent | |
| CN104027280B (en) | A kind of delay aging drug compositions and the application in cosmetics thereof | |
| CN106473946A (en) | A kind of anti-acne elite dew and preparation method thereof | |
| BR112012030006A2 (en) | topical pharmaceutical compositions | |
| US10588979B1 (en) | Cannabinoid and terpene-infused topical cream | |
| JP4835411B2 (en) | Adapalene-containing external preparation composition | |
| CN108567683A (en) | A kind of self-control dimension E oat masks | |
| JP2017075111A (en) | External composition | |
| CN107865784A (en) | A kind of nanosized micelles toner based on collaboration whitening function | |
| JP2008255017A (en) | Adapalene-containing composition for external use | |
| CN105287322A (en) | Antibacterial talcum powder and method for preparing same | |
| CN108685826A (en) | A kind of anti-acne essence with anti-inflammatory properties | |
| CN103784377A (en) | Whitening mask liquid | |
| KR20140120652A (en) | Cosmetics composition comprising phosphatidylcholine and vanillyl butyl ether and method of fabricating thereof | |
| JP2012254957A (en) | External skin preparation and production method thereof | |
| JP2008184442A (en) | Adapalene-containing external preparation composition | |
| CN105125908A (en) | Traditional Chinese ointment for acne removal | |
| CN104083312A (en) | Acne-removing formula | |
| JP2013199485A (en) | Adapalene-containing external preparation composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170308 |